3TBiosciences
Latest round
- Series A
Last raised
- Jul 2021
Total raised
- $61M
Investors
- 3
About 3TBiosciences
3T Biosciences, Inc.Founded in 2017 in South San Francisco, US, 3T Biosciences specializes in TCR therapeutics.3T Biosciences specializes in transformative T-cell receptor (TCR) therapeutics, focusing on TCR target identification and therapeutic discovery. Their core offerings revolve around advanced biotechnological solutions aimed at enhancing immunotherapy treatments for cancer and other diseases. The company employs proprietary technologies to discover and develop TCRs that can recognize and bind to specific antigens presented by cancer cells, which is crucial for effective targeted therapies. These products are particularly relevant for oncologists and researchers in the biopharmaceutical sector, seeking innovative approaches to improve patient outcomes.3T Biosciences' revenue model is predominantly centered around partnerships and collaborations with pharmaceutical companies, research institutions, and healthcare providers. The company engages in B2B transactions where they license their proprietary technologies and therapeutics to partner organizations, allowing for shared development and commercialization efforts. This structure promotes innovation while providing a revenue stream from licensing fees and potential milestone payments upon achieving specific clinical development targets. The company is focusing on expanding into new markets, particularly in Europe, where they see significant potential for their immunotherapy solutions.
Who invested in 3TBiosciences
3 investors across 2 rounds
See all investors in 3TBiosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about 3TBiosciences
Who invested in 3TBiosciences?
3TBiosciences has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 3TBiosciences raised?
3TBiosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did 3TBiosciences last raise money?
3TBiosciences's most recent round on record is a Series A, in Jul 2021.
What does 3TBiosciences do?
3TBiosciences is a healthcare specialists company.
Where is 3TBiosciences headquartered?
3TBiosciences is headquartered in South San Francisco, US.
Which VCs invest in companies like 3TBiosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at 3TBiosciences's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like 3TBiosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.